Guangdong Raynovent Biotech Co., Ltd
Clinical trials sponsored by Guangdong Raynovent Biotech Co., Ltd, explained in plain language.
-
New flu drug for kids shows promise in Late-Stage trial
Symptom relief OngoingThis study tests a medicine called ZSP1273 in children aged 2 to 11 who have influenza A. The goal is to see if it safely reduces flu symptoms like fever and cough. About 119 children in China are taking part. The medicine is given as granules, which are easy for kids to take.
Phase: PHASE3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated May 17, 2026 11:23 UTC
-
New flu pill for teens shows promise in major trial
Symptom relief OngoingThis study tests a new tablet called ZSP1273 in teenagers aged 12 to 17 with mild influenza A. Half get the drug, half get a placebo, and researchers track how fast flu symptoms like cough, fever, and body aches go away. The goal is to see if the drug is safe and speeds up recove…
Phase: PHASE3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
New obesity drug put through safety check with common meds
Knowledge-focused OngoingThis early-stage study checks how a new experimental drug for obesity, called RAY1225, affects the way the body processes four common medications: warfarin, atorvastatin, metformin, and digoxin. Thirty-two healthy adults will take RAY1225 along with these drugs to see if any dang…
Phase: PHASE1 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Knowledge-focused
Last updated May 17, 2026 11:19 UTC